title: Clinical-pregnancy outcome after vitrification of blastocysts produced from in vitro maturation cycles.
abstract: This study was conducted to report the clinical-pregnancy outcome after vitrification of the blastocysts produced from in vitro maturation cycles. The survival rate after thawing was 92.0% (92/100). The clinical-pregnancy and implantation rates were 43.8% and 23.6%, respectively. These results suggest that the blastocyst-stage embryos produced from in vitro maturation cycles can be safely cryopreserved through vitrification.
authors.affiliation: Maria Infertility Hospital, Seoul, Korea.
authors.forename: Seok-Yoon
authors.initials: SY
authors.lastname: Lee
authors.forename: Weon-Young
authors.initials: WY
authors.lastname: Son
authors.forename: San-Hyun
authors.initials: SH
authors.lastname: Yoon
authors.forename: Jin-Ho
authors.initials: JH
authors.lastname: Lim
mesh_terms: D000328:Adult; D001755:Blastocyst / Q000166:cytology / Q000502:physiology*; D015925:Cryopreservation / Q000379:methods*; D004624:Embryo Transfer / Q000379:methods; D005260:Female; D005307:Fertilization in Vitro / Q000379:methods*; D006801:Humans; D007247:Infertility, Female / Q000628:therapy; D011247:Pregnancy; D011256:Pregnancy Outcome